# GSK Vaccines GmbH – FDA 483, Feb 27, 2026

Source: https://www.keypedia.com/records/483/gsk-vaccines-gmbh/30966473-67d9-4456-b7b4-4427fb524ed0

> FDA 483 for GSK Vaccines GmbH on February 27, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: GSK Vaccines GmbH
- Inspection Date: 2026-02-27
- Product Type: biologics
- Office Name: Office of Inspections and Investigations
- Summary: GSK Vaccines GmbH, a licensed biological drug manufacturer in Marburg, Germany, was cited for significant deficiencies in its Aluminum Hydroxide adjuvant production. The inspection revealed unvalidated cleaning procedures, inadequate cleaning verification monitoring, and a failure to properly investigate recurring cleaning failures for dedicated equipment. Furthermore, the firm did not thoroughly review unexplained discrepancies or conduct formal investigations for repeated test failures related to the adjuvant filling equipment, impacting U.S. licensed products.

## Related Documents

- [483 - 2024-11-12](https://www.keypedia.com/records/483/gsk-vaccines-gmbh/e21968a3-1d7b-42f1-8fa8-1ed4226e287e) — date: November 12, 2024
- [483 - 2024-03-06](https://www.keypedia.com/records/483/gsk-vaccines-gmbh/17a156b1-1d2c-45e5-a69d-7e981fede4f2) — date: March 6, 2024

## Related Officers

- [Investigator](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)
- [Travis S. Bradley](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/gsk-vaccines-gmbh/af5a9fae-fd5f-4aad-b88d-666e8cf72794

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8